Eisai CEO Naito

Eisai CEO Naito

Haruo Naito, CEO of Japanese pharmaceutical company Eisai Co., speaks during a press conference in Tokyo on July 7, 2023, after the U.S. Food and Drug Administration granted full approval for Eisai and Biogen Inc.'s anti-Alzheimer's drug lecanemab.

  • Product Code
  • ILEA001501492
  • Registered date
  • 2023/7/07 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2023 Kyodo News
  • Media size
  • 3649 × 2806 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 538.88(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos